Claudia Ordonez

Insider Reports History

Location
Lexington, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Claudia Ordonez:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 98,211 11 Jun 2021 Direct
Keros Therapeutics, Inc. Chief Medical Officer Common Stock 0 $45.29 11 Jun 2021 Direct

Insider Reports Filed by Claudia Ordonez

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 11 Jun 2021 4 -$50,510 4 Chief Medical Officer 15 Jun 2021, 17:01
KROS Keros Therapeutics, Inc. 11 May 2021 3 -$49,670 4 Chief Medical Officer 13 May 2021, 16:37